[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.48.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1981

Hypophosphatemia in a Patient With Lymphoma in Leukemic Phase

Author Affiliations

From the Departments of Hematology (Drs Matzner, Prococimer, and Polliack) and Nephrology (Drs Rubinger and Popovtzer), Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem.

Arch Intern Med. 1981;141(6):805-806. doi:10.1001/archinte.1981.00340060113028
Abstract

• A patient with histiocytic lymphoma had abdominal masses, hypophosphatemia, normocalcemia, and a normal serum parathyroid hormone value. After chemotherapy, transient hyperphosphatemia ensued, the abdominal masses resolved, and other manifestations of the disease were suppressed. One week after discontinuation of the chemotherapy, the abdominal masses and other signs indicative of reactivation of the malignant disease reappeared. During the relapse, the serum phosphorus level fell to 0.7 mg/dL, and urinary excretion of phosphorus became negligible. After resumption of chemotherapy, serum concentration and urinary excretion of phosphorus increased. These observations suggest that severe hypophosphatemia may be a complication of hematologic neoplasia. It is proposed that this abnormality may be caused by a shift of excessive amounts of extracellular phosphorus into the rapidly replicating malignant cells.

(Arch Intern Med 1981;141:805-806)

×